alpha-1 Adrenergic Agonist [EPC]

alpha-1 Adrenergic Agonist [EPC] was reported 4434 times

Drugs of the alpha-1 Adrenergic Agonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 CEREBRAL ARTERY STENT INSERTION 5 0.8333
1 FOETAL CARDIAC ARREST 4 0.2353
2 ANTERIOR SPINAL ARTERY SYNDROME 10 0.1190
3 FLOPPY IRIS SYNDROME 39 0.1060
4 FIBRIN 4 0.0930
5 SYNOVIAL FLUID ANALYSIS 8 0.0920
6 AQUEOUS FIBRIN 4 0.0784
7 TOXIC ANTERIOR SEGMENT SYNDROME 82 0.0752
8 TRIGEMINO-CARDIAC REFLEX 6 0.0741
9 BASELINE FOETAL HEART RATE VARIABILITY DISORDER 4 0.0727
10 CORNEAL STRIAE 5 0.0704
11 OESOPHAGEAL INTRAMURAL HAEMATOMA 7 0.0667
12 ERYTHROBLAST COUNT INCREASED 4 0.0667
13 MATERNAL EXPOSURE DURING DELIVERY 65 0.0656
14 HYPOTENSIVE TRANSFUSION REACTION 4 0.0606
15 CUTANEOUS MUCORMYCOSIS 11 0.0598
16 VASCULAR RESISTANCE SYSTEMIC DECREASED 8 0.0597
17 BURKHOLDERIA TEST POSITIVE 7 0.0565
18 FOETAL EXPOSURE DURING DELIVERY 33 0.0487
19 SUBRETINAL FIBROSIS 9 0.0462
20 SINUS RHYTHM 20 0.0459
21 POSTOPERATIVE DELIRIUM 9 0.0455
22 TOTAL LUNG CAPACITY INCREASED 12 0.0441
23 MEAN ARTERIAL PRESSURE DECREASED 11 0.0435
24 RETINAL DRUSEN 7 0.0427
25 RETINAL CYST 7 0.0422
26 RENAL ISCHAEMIA 20 0.0366
27 EYE NAEVUS 4 0.0351
28 PITYRIASIS RUBRA PILARIS 8 0.0336
29 PARKINSONISM HYPERPYREXIA SYNDROME 6 0.0335
30 ALLERGIC TRANSFUSION REACTION 5 0.0331
31 CATARACT NUCLEAR 22 0.0330
32 PO2 INCREASED 16 0.0316
33 IRIDOCELE 4 0.0308
34 DRY GANGRENE 19 0.0299
35 VITREAL CELLS 6 0.0297
36 CUTIS LAXA 8 0.0294
37 VENTILATION PERFUSION MISMATCH 8 0.0285
38 DERMATOCHALASIS 4 0.0272
39 CATARACT CORTICAL 4 0.0268
40 PCO2 INCREASED 19 0.0267
41 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 9 0.0259
42 VASOPLEGIA SYNDROME 42 0.0256
43 WRONG PRODUCT STORED 7 0.0246
44 RHYTHM IDIOVENTRICULAR 8 0.0246
45 HYPERDYNAMIC LEFT VENTRICLE 6 0.0244
46 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 12 0.0229
47 HYPERTENSIVE EMERGENCY 26 0.0221
48 BRADYCARDIA FOETAL 18 0.0217
49 PROCEDURAL HYPOTENSION 18 0.0212
50 MACULAR SCAR 4 0.0206
51 RETINAL ANEURYSM 4 0.0200
52 SYNOVIAL DISORDER 9 0.0198
53 RED BLOOD CELL SEDIMENTATION RATE DECREASED 5 0.0192
54 DIABETES INSIPIDUS 46 0.0191
55 RETINOGRAM ABNORMAL 5 0.0187
56 PROPOFOL INFUSION SYNDROME 13 0.0184
57 PRODUCT APPEARANCE CONFUSION 17 0.0184
58 DISTRIBUTIVE SHOCK 41 0.0181
59 DIABETIC RETINAL OEDEMA 9 0.0177
60 CHOROIDAL NEOVASCULARISATION 15 0.0175
61 ANTERIOR CHAMBER DISORDER 4 0.0174
62 TENOSYNOVITIS STENOSANS 9 0.0162
63 PUPILLARY LIGHT REFLEX TESTS ABNORMAL 5 0.0161
64 CHOROIDITIS 6 0.0160
65 ANTERIOR CHAMBER CELL 11 0.0154
66 MACULAR FIBROSIS 10 0.0147
67 MACROGLOSSIA 8 0.0145
68 ANAESTHETIC COMPLICATION NEUROLOGICAL 13 0.0143
69 HYPOTONY OF EYE 6 0.0143
70 SCHIZOAFFECTIVE DISORDER 25 0.0140
71 CEREBRAL VASOCONSTRICTION 10 0.0135
72 ANTERIOR CHAMBER INFLAMMATION 8 0.0134
73 PERINEAL ABSCESS 6 0.0133
74 MEIBOMIAN GLAND DYSFUNCTION 6 0.0132
75 VISUAL ACUITY REDUCED TRANSIENTLY 4 0.0130
76 PRODUCT PACKAGING CONFUSION 31 0.0128
77 FOETAL HEART RATE DECELERATION ABNORMALITY 9 0.0127
78 GENITAL ABSCESS 5 0.0124
79 UNWANTED AWARENESS DURING ANAESTHESIA 4 0.0122
80 BLOOD BICARBONATE DECREASED 23 0.0121
81 HYPOPYON 10 0.0121
82 CORNEAL OEDEMA 27 0.0120
83 CANDIDA TEST POSITIVE 5 0.0120
84 BLOOD PH DECREASED 20 0.0117
85 BACTERIAL ENDOPHTHALMITIS 3 0.0113
86 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 10 0.0112
87 CONGESTIVE HEPATOPATHY 5 0.0112
88 HEPATIC ENZYME DECREASED 5 0.0111
89 NECROTISING COLITIS 14 0.0110
90 ABDOMINAL COMPARTMENT SYNDROME 7 0.0110
91 RETINAL SCAR 5 0.0108
92 NECROSIS ISCHAEMIC 5 0.0108
93 PSYCHOGENIC SEIZURE 10 0.0107
94 VITREOUS DETACHMENT 23 0.0106
95 SCROTAL ABSCESS 4 0.0106
96 ENDOCRINE OPHTHALMOPATHY 9 0.0104
97 CATARACT SUBCAPSULAR 6 0.0098
98 RETINAL ISCHAEMIA 6 0.0098
99 NORMAL NEWBORN 53 0.0097
100 CYSTOID MACULAR OEDEMA 18 0.0095
101 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 10 0.0094
102 NECROTISING RETINITIS 6 0.0094
103 STRESS CARDIOMYOPATHY 52 0.0089
104 PUPILS UNEQUAL 10 0.0087
105 LARYNGEAL STENOSIS 5 0.0087
106 FANCONI SYNDROME 12 0.0085
107 TRYPTASE INCREASED 6 0.0084
108 PRIAPISM 29 0.0084
109 AMAUROSIS 7 0.0083
110 RESPIRATORY ACIDOSIS 32 0.0081
111 OXYGEN SATURATION ABNORMAL 23 0.0081
112 INTRAOCULAR LENS IMPLANT 4 0.0081
113 ISCHAEMIC HEPATITIS 11 0.0080
114 FOETAL HEART RATE DECREASED 5 0.0080
115 ALKALOSIS 3 0.0079
116 GLARE 4 0.0078
117 RETINAL INJURY 6 0.0078
118 CEREBELLAR INFARCTION 13 0.0077
119 CLONUS 21 0.0077
120 PULSELESS ELECTRICAL ACTIVITY 32 0.0077
121 ENDOPHTHALMITIS 45 0.0075
122 RETINAL EXUDATES 7 0.0075
123 LIVE BIRTH 62 0.0074
124 HYPERTENSIVE URGENCY 4 0.0072
125 VITREOUS OPACITIES 6 0.0071
126 VITRITIS 13 0.0070
127 NODAL ARRHYTHMIA 6 0.0070
128 ELECTROENCEPHALOGRAM ABNORMAL 22 0.0070
129 PUPIL FIXED 12 0.0069
130 PERIPHERAL ISCHAEMIA 28 0.0068
131 RETINAL TOXICITY 7 0.0068
132 PRODUCT LABEL CONFUSION 39 0.0067
133 SYSTOLIC DYSFUNCTION 7 0.0066
134 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 13 0.0066
135 VASOSPASM 6 0.0065
136 ARTERIOSPASM CORONARY 26 0.0065
137 PREMATURE DELIVERY 103 0.0065
138 ALLERGY TO CHEMICALS 8 0.0064
139 PRODUCT NAME CONFUSION 7 0.0064
140 ARRHYTHMIA SUPRAVENTRICULAR 7 0.0064
141 SUBRETINAL FLUID 7 0.0064
142 DELAYED RECOVERY FROM ANAESTHESIA 6 0.0063
143 ANION GAP 4 0.0063
144 RETINAL OEDEMA 12 0.0063
145 RETINAL DEGENERATION 8 0.0062
146 PHAEOCHROMOCYTOMA 4 0.0061
147 DYSCHROMATOPSIA 5 0.0060
148 VASOCONSTRICTION 5 0.0057
149 OEDEMA MUCOSAL 6 0.0057
150 SCLERITIS 9 0.0056
151 BRADYARRHYTHMIA 9 0.0055
152 CERUMEN IMPACTION 5 0.0055
153 METAMORPHOPSIA 10 0.0054
154 PUPILLARY REFLEX IMPAIRED 10 0.0054
155 VITREOUS FLOATERS 52 0.0053
156 SPINAL CORD INJURY 9 0.0052
157 EXTREMITY NECROSIS 9 0.0052
158 HAEMOPHILUS INFECTION 5 0.0051
159 GROIN ABSCESS 6 0.0051
160 ACIDOSIS HYPERCHLORAEMIC 3 0.0051
161 RETINAL DISORDER 13 0.0050
162 MACULAR OEDEMA 28 0.0050
163 LOW BIRTH WEIGHT BABY 39 0.0049
164 METHAEMOGLOBINAEMIA 11 0.0047
165 ENTEROCOCCAL BACTERAEMIA 5 0.0047
166 NON-INFECTIOUS ENDOPHTHALMITIS 4 0.0047
167 VENTRICULAR HYPOKINESIA 15 0.0047
168 CARDIOGENIC SHOCK 67 0.0047
169 OCULAR HYPERTENSION 9 0.0046
170 HAEMODYNAMIC INSTABILITY 35 0.0046
171 GASTROINTESTINAL TOXICITY 22 0.0046
172 PRODUCT SELECTION ERROR 5 0.0046
173 CORNEAL DISORDER 10 0.0046
174 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 10 0.0045
175 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 15 0.0045
176 PERIRECTAL ABSCESS 5 0.0045
177 ANAESTHETIC COMPLICATION 12 0.0045
178 TACHYARRHYTHMIA 11 0.0044
179 CORNEAL OPACITY 6 0.0044
180 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 6 0.0043
181 SCROTAL SWELLING 4 0.0043
182 DEAFNESS NEUROSENSORY 14 0.0043
183 PRODUCT CONTAMINATION MICROBIAL 5 0.0042
184 LEFT VENTRICULAR DYSFUNCTION 28 0.0042
185 NODAL RHYTHM 6 0.0041
186 IDIOSYNCRATIC DRUG REACTION 4 0.0041
187 RHINITIS ALLERGIC 18 0.0040
188 PREMATURE BABY 121 0.0040
189 FACET JOINT SYNDROME 13 0.0040
190 NEONATAL RESPIRATORY DISTRESS SYNDROME 14 0.0040
191 RETINAL HAEMORRHAGE 28 0.0039
192 APGAR SCORE LOW 5 0.0039
193 CAPILLARY LEAK SYNDROME 8 0.0039
194 FOETAL DEATH 20 0.0039
195 PULSE ABSENT 18 0.0038
196 ISCHAEMIA 17 0.0037
197 PULMONARY ARTERIAL PRESSURE INCREASED 6 0.0037
198 OTITIS MEDIA 12 0.0036
199 PLEURITIC PAIN 10 0.0036
200 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 18 0.0035
201 THERAPEUTIC PRODUCT EFFECT INCREASED 4 0.0034
202 C-REACTIVE PROTEIN ABNORMAL 22 0.0034
203 JAUNDICE CHOLESTATIC 12 0.0034
204 GENITAL PAIN 5 0.0034
205 CREPITATIONS 10 0.0034
206 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 17 0.0034
207 X-RAY ABNORMAL 6 0.0034
208 ANAEMIA OF CHRONIC DISEASE 3 0.0033
209 HYPOMANIA 12 0.0033
210 VITREOUS HAEMORRHAGE 9 0.0033
211 HYPERTROPHIC CARDIOMYOPATHY 5 0.0032
212 SINUS ARREST 5 0.0032
213 ELECTROCARDIOGRAM T WAVE INVERSION 7 0.0032
214 CONJUNCTIVAL HAEMORRHAGE 12 0.0031
215 ANGLE CLOSURE GLAUCOMA 8 0.0031
216 NECROTISING FASCIITIS 11 0.0031
217 PULMONARY TOXICITY 22 0.0031
218 BLADDER CATHETERISATION 3 0.0031
219 KOUNIS SYNDROME 7 0.0031
220 TONIC CLONIC MOVEMENTS 4 0.0031
221 RESPIRATORY ALKALOSIS 5 0.0031
222 DISLOCATION OF VERTEBRA 7 0.0031
223 HYPERAEMIA 6 0.0030
224 DEEP VEIN THROMBOSIS POSTOPERATIVE 6 0.0030
225 DUODENAL ULCER PERFORATION 22 0.0030
226 METABOLIC ACIDOSIS 94 0.0029
227 CORNEAL ABRASION 4 0.0029
228 RHEUMATOID NODULE 8 0.0029
229 TENOSYNOVITIS 8 0.0029
230 CATATONIA 15 0.0029
231 ACUTE PULMONARY OEDEMA 16 0.0028
232 BRADYCARDIA 150 0.0028
233 SEROTONIN SYNDROME 54 0.0028
234 CONJUNCTIVAL HYPERAEMIA 10 0.0028
235 HYPERPARATHYROIDISM SECONDARY 7 0.0028
236 PORPHYRIA ACUTE 4 0.0028
237 RESPIRATORY DEPRESSION 34 0.0028
238 SARCOIDOSIS 13 0.0027
239 GANGRENE 16 0.0027
240 SHOCK 61 0.0026
241 PREMATURE SEPARATION OF PLACENTA 4 0.0026
242 BRADYPNOEA 7 0.0026
243 NEPHROGENIC ANAEMIA 12 0.0026
244 CARDIOMYOPATHY 38 0.0026
245 BLOOD MAGNESIUM DECREASED 22 0.0025
246 VENTRICULAR FIBRILLATION 28 0.0025
247 SWOLLEN JOINT COUNT INCREASED 8 0.0025
248 CUSHINGOID 8 0.0025
249 MATERNAL EXPOSURE DURING PREGNANCY 221 0.0025
250 RHEUMATIC FEVER 11 0.0025
251 ANTINUCLEAR ANTIBODY POSITIVE 8 0.0025
252 VENTRICULAR ARRHYTHMIA 9 0.0025
253 NASAL POLYPS 12 0.0024
254 HEPARIN-INDUCED THROMBOCYTOPENIA 12 0.0024
255 SPINAL CORD DISORDER 4 0.0024
256 DRUG LEVEL INCREASED 40 0.0024
257 MYDRIASIS 31 0.0024
258 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 5 0.0024
259 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 23 0.0024
260 CIRCULATORY COLLAPSE 41 0.0024
261 PHOTOPSIA 15 0.0024
262 ACIDOSIS 18 0.0024
263 DIABETIC RETINOPATHY 8 0.0024
264 RENAL TUBULAR NECROSIS 23 0.0023
265 HYPERCAPNIA 7 0.0023
266 ATRIOVENTRICULAR BLOCK SECOND DEGREE 7 0.0023
267 STATUS EPILEPTICUS 26 0.0023
268 PROCEDURAL HAEMORRHAGE 9 0.0023
269 HYPOVOLAEMIC SHOCK 11 0.0023
270 ENCEPHALOPATHY 56 0.0023
271 FANCONI SYNDROME ACQUIRED 4 0.0023
272 HYPOTHERMIA 23 0.0023
273 HELICOBACTER INFECTION 23 0.0022
274 HYPERLACTACIDAEMIA 6 0.0022
275 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 16 0.0022
276 DRUG MONITORING PROCEDURE NOT PERFORMED 4 0.0022
277 BRONCHIECTASIS 15 0.0022
278 HYPOXIA 78 0.0022
279 LOBAR PNEUMONIA 4 0.0022
280 HEPATOTOXICITY 48 0.0022
281 EXPOSURE DURING PREGNANCY 133 0.0021
282 ACUTE RESPIRATORY FAILURE 40 0.0021
283 CARDIOPULMONARY FAILURE 8 0.0020
284 NASAL SEPTUM DEVIATION 4 0.0020
285 BLOOD CALCIUM DECREASED 23 0.0020
286 LACTIC ACIDOSIS 66 0.0020
287 MULTI-ORGAN DISORDER 4 0.0020
288 RETINAL TEAR 5 0.0020
289 APRAXIA 3 0.0020
290 INTRAVENTRICULAR HAEMORRHAGE 5 0.0020
291 INFUSION SITE REACTION 6 0.0020
292 INTESTINAL ISCHAEMIA 11 0.0020
293 CORONARY ARTERY THROMBOSIS 4 0.0020
294 MULTIPLE ORGAN DYSFUNCTION SYNDROME 56 0.0020
295 PERIPHERAL VENOUS DISEASE 8 0.0020
296 SYNOVIAL CYST 9 0.0019
297 HYPOTENSION 388 0.0019
298 OLIGURIA 12 0.0019
299 VISUAL ACUITY REDUCED 64 0.0019
300 WRONG PRODUCT ADMINISTERED 13 0.0019
301 TORSADE DE POINTES 15 0.0019
302 BLOOD LACTIC ACID INCREASED 10 0.0019
303 BUNDLE BRANCH BLOCK LEFT 8 0.0019
304 EXOPHTHALMOS 4 0.0019
305 MITRAL VALVE INCOMPETENCE 21 0.0019
306 PLEURISY 11 0.0019
307 TROPONIN INCREASED 14 0.0018
308 CARDIAC ARREST 151 0.0018
309 HYPERVOLAEMIA 9 0.0018
310 INTENTIONAL OVERDOSE 115 0.0018
311 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 4 0.0018
312 COMPLICATIONS OF TRANSPLANTED KIDNEY 4 0.0018
313 ATELECTASIS 17 0.0018
314 VENTRICULAR TACHYCARDIA 29 0.0018
315 PNEUMATOSIS INTESTINALIS 5 0.0018
316 ACUTE RESPIRATORY DISTRESS SYNDROME 31 0.0018
317 ACUTE SINUSITIS 3 0.0017
318 FOETAL EXPOSURE DURING PREGNANCY 139 0.0017
319 AORTIC VALVE STENOSIS 3 0.0017
320 INTRA-ABDOMINAL HAEMORRHAGE 4 0.0017
321 HAND DEFORMITY 22 0.0017
322 APNOEA 13 0.0017
323 ONYCHOMADESIS 7 0.0017
324 METABOLIC ENCEPHALOPATHY 5 0.0017
325 BURSITIS 20 0.0016
326 FOETAL GROWTH RESTRICTION 10 0.0016
327 COLITIS ISCHAEMIC 11 0.0016
328 FOLLICULITIS 17 0.0016
329 BRAIN DEATH 5 0.0016
330 CARDIAC MURMUR 14 0.0016
331 HYPERNATRAEMIA 8 0.0016
332 BLEPHAROSPASM 10 0.0016
333 PHYSICAL DISABILITY 7 0.0016
334 UPPER-AIRWAY COUGH SYNDROME 13 0.0016
335 DEPRESSED LEVEL OF CONSCIOUSNESS 62 0.0016
336 RHEUMATOID FACTOR POSITIVE 9 0.0016
337 BREAST CANCER STAGE III 10 0.0015
338 MUCORMYCOSIS 4 0.0015
339 HAEMORRHAGE INTRACRANIAL 23 0.0015
340 HYPOVOLAEMIA 9 0.0015
341 ABDOMINAL WALL HAEMATOMA 3 0.0015
342 HYPOVENTILATION 5 0.0015
343 COMPARTMENT SYNDROME 4 0.0015
344 ELECTROCARDIOGRAM QT PROLONGED 55 0.0015
345 THERAPY NON-RESPONDER 68 0.0015
346 JOINT RANGE OF MOTION DECREASED 20 0.0015
347 NAIL DISORDER 13 0.0015
348 BLOOD SODIUM INCREASED 4 0.0015
349 SINUS TACHYCARDIA 21 0.0015
350 SEPTIC SHOCK 63 0.0014
351 TACHYPHRENIA 5 0.0014
352 HYPOPNOEA 5 0.0014
353 LUNG CONSOLIDATION 4 0.0014
354 ENDOTRACHEAL INTUBATION 4 0.0014
355 DISSEMINATED INTRAVASCULAR COAGULATION 20 0.0014
356 PREMATURE LABOUR 8 0.0014
357 BONE EROSION 5 0.0014
358 INTRAOCULAR PRESSURE INCREASED 18 0.0014
359 MYOCARDIAL ISCHAEMIA 16 0.0014
360 PRODUCT CONTAMINATION 5 0.0014
361 ACUTE HEPATIC FAILURE 19 0.0014
362 EYE INFLAMMATION 13 0.0014
363 PULMONARY OEDEMA 61 0.0014
364 PEMPHIGUS 17 0.0014
365 EJECTION FRACTION DECREASED 21 0.0013
366 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 8 0.0013
367 ATRIOVENTRICULAR BLOCK COMPLETE 9 0.0013
368 BRAIN HERNIATION 4 0.0013
369 MUSCLE INJURY 11 0.0013
370 PRODUCT LABEL ISSUE 9 0.0013
371 IRITIS 4 0.0013
372 KERATITIS 4 0.0013
373 JOINT EFFUSION 9 0.0013
374 POST PROCEDURAL COMPLICATION 25 0.0013
375 DIASTOLIC DYSFUNCTION 4 0.0013
376 RESPIRATORY FAILURE 94 0.0013
377 TALIPES 4 0.0013
378 WOUND INFECTION 14 0.0013
379 CREATININE RENAL CLEARANCE DECREASED 5 0.0012
380 BLEPHARITIS 5 0.0012
381 LOWER GASTROINTESTINAL HAEMORRHAGE 9 0.0012
382 ANAPHYLACTOID REACTION 5 0.0012
383 RETINAL DETACHMENT 11 0.0012
384 BRONCHOSPASM 17 0.0012
385 BK VIRUS INFECTION 4 0.0012
386 TOXIC EPIDERMAL NECROLYSIS 18 0.0012
387 SUPRAVENTRICULAR EXTRASYSTOLES 4 0.0012
388 TACHYCARDIA 105 0.0012
389 PNEUMONIA ASPIRATION 29 0.0012
390 HYPOALBUMINAEMIA 9 0.0012
391 ACUTE KIDNEY INJURY 177 0.0012
392 HYPERTRANSAMINASAEMIA 8 0.0011
393 HYPERCHOLESTEROLAEMIA 11 0.0011
394 SINUS BRADYCARDIA 11 0.0011
395 MACULOPATHY 4 0.0011
396 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 19 0.0011
397 VISUAL FIELD DEFECT 8 0.0011
398 SHOCK HAEMORRHAGIC 9 0.0011
399 FEELING JITTERY 21 0.0011
400 MULTI-ORGAN FAILURE 19 0.0011
401 BRAIN INJURY 11 0.0011
402 HAEMOGLOBIN INCREASED 5 0.0011
403 ASTHMATIC CRISIS 4 0.0011
404 BUNDLE BRANCH BLOCK RIGHT 5 0.0011
405 GENERALISED TONIC-CLONIC SEIZURE 18 0.0011
406 JOINT INJURY 23 0.0011
407 PERICARDITIS 18 0.0011
408 DEFORMITY 10 0.0011
409 SCHIZOPHRENIA 13 0.0011
410 HYPOGAMMAGLOBULINAEMIA 7 0.0011
411 PHOTOPHOBIA 20 0.0011
412 LEUKOCYTOSIS 19 0.0010
413 END STAGE RENAL DISEASE 19 0.0010
414 ATRIOVENTRICULAR BLOCK 8 0.0010
415 FINGER DEFORMITY 5 0.0010
416 ANAPHYLACTIC REACTION 57 0.0010
417 POST PROCEDURAL HAEMORRHAGE 12 0.0010
418 SPINAL OSTEOARTHRITIS 9 0.0010
419 INFARCTION 7 0.0010
420 ACUTE MYOCARDIAL INFARCTION 30 0.0010
421 DELIRIUM 35 0.0010
422 UNRESPONSIVE TO STIMULI 26 0.0010
423 LIP DRY 9 0.0010
424 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 54 0.0010
425 LIVER INJURY 24 0.0010
426 MENTAL STATUS CHANGES 27 0.0010
427 PERIORBITAL OEDEMA 5 0.0010
428 RED CELL DISTRIBUTION WIDTH INCREASED 4 0.0010
429 BREAST CANCER STAGE II 8 0.0010
430 COAGULOPATHY 16 0.0010
431 FLANK PAIN 9 0.0010
432 FIBROMYALGIA 23 0.0009
433 ABSCESS LIMB 4 0.0009
434 ANAL ABSCESS 5 0.0009
435 AUTOIMMUNE DISORDER 9 0.0009
436 ATRIOVENTRICULAR BLOCK FIRST DEGREE 4 0.0009
437 DRUG INTERACTION 145 0.0009
438 PROCEDURAL COMPLICATION 7 0.0009
439 ONYCHOMYCOSIS 4 0.0009
440 GRIP STRENGTH DECREASED 8 0.0009
441 CARDIAC FAILURE ACUTE 6 0.0009
442 HYPERTENSIVE CRISIS 10 0.0009
443 FLUID OVERLOAD 13 0.0009
444 CONTRAINDICATED PRODUCT ADMINISTERED 27 0.0009
445 TYPE 2 DIABETES MELLITUS 30 0.0009
446 ILEUS 11 0.0009
447 UVEITIS 12 0.0009
448 PERIORBITAL SWELLING 5 0.0009
449 BLOOD PRESSURE SYSTOLIC DECREASED 4 0.0009
450 OBESITY 14 0.0009
451 TENDERNESS 9 0.0009
452 METABOLIC DISORDER 5 0.0009
453 CAESAREAN SECTION 10 0.0009
454 GLOSSODYNIA 19 0.0008
455 PROTHROMBIN TIME PROLONGED 5 0.0008
456 SUPRAVENTRICULAR TACHYCARDIA 8 0.0008
457 SUBCUTANEOUS ABSCESS 4 0.0008
458 KIDNEY TRANSPLANT REJECTION 4 0.0008
459 FAECAL INCONTINENCE 4 0.0008
460 SYNOVITIS 15 0.0008
461 THERAPEUTIC PRODUCT EFFECT DECREASED 37 0.0008
462 EYE PAIN 46 0.0008
463 BLINDNESS TRANSIENT 6 0.0008
464 CARDIOMEGALY 10 0.0008
465 CONCOMITANT DISEASE AGGRAVATED 5 0.0008
466 TACHYPNOEA 11 0.0008
467 RENAL INJURY 24 0.0008
468 TOXICITY TO VARIOUS AGENTS 136 0.0008
469 ANEURYSM 4 0.0008
470 INTESTINAL PERFORATION 9 0.0008
471 HYDRONEPHROSIS 6 0.0008
472 HYPERAMMONAEMIA 4 0.0008
473 COMA 38 0.0008
474 CYTOKINE RELEASE SYNDROME 16 0.0008
475 LUNG INFILTRATION 7 0.0008
476 LIVER FUNCTION TEST INCREASED 17 0.0008
477 RENAL FAILURE CHRONIC 6 0.0008
478 PRODUCT PREPARATION ERROR 16 0.0008
479 BLOOD BILIRUBIN INCREASED 21 0.0008
480 HAEMOLYSIS 6 0.0008
481 ANAPHYLACTIC SHOCK 20 0.0008
482 PALLOR 21 0.0008
483 PULMONARY HYPERTENSION 16 0.0008
484 HEMIPARESIS 13 0.0008
485 NODULE 10 0.0008
486 RASH MACULO-PAPULAR 17 0.0008
487 JOINT STIFFNESS 20 0.0008
488 MACULAR DEGENERATION 9 0.0008
489 AZOTAEMIA 3 0.0008
490 TUBULOINTERSTITIAL NEPHRITIS 14 0.0007
491 IRRITABLE BOWEL SYNDROME 16 0.0007
492 RHINITIS 6 0.0007
493 CARDIO-RESPIRATORY ARREST 31 0.0007
494 NO THERAPEUTIC RESPONSE 9 0.0007
495 BLINDNESS 30 0.0007
496 EMBOLISM 6 0.0007
497 BLOOD PRESSURE DECREASED 48 0.0007
498 INTRACRANIAL PRESSURE INCREASED 4 0.0007
499 RIGHT VENTRICULAR FAILURE 5 0.0007
500 HYPERKALAEMIA 25 0.0007
501 BRAIN OEDEMA 9 0.0007
502 BLINDNESS UNILATERAL 10 0.0007
503 RENAL FAILURE ACUTE 30 0.0007
504 PRODUCT USE COMPLAINT 11 0.0007
505 CEREBRAL INFARCTION 17 0.0007
506 PANIC REACTION 5 0.0007
507 SCIATICA 11 0.0007
508 SUBARACHNOID HAEMORRHAGE 7 0.0007
509 MUSCULOSKELETAL PAIN 36 0.0007
510 EAR DISCOMFORT 7 0.0007
511 WOUND 19 0.0007
512 WHEEZING 40 0.0007
513 ATAXIA 8 0.0007
514 QUALITY OF LIFE DECREASED 9 0.0007
515 MYOCLONUS 8 0.0007
516 HYPERLIPIDAEMIA 8 0.0007
517 SEIZURE 77 0.0007
518 INTERNATIONAL NORMALISED RATIO INCREASED 19 0.0007
519 RENAL FAILURE 88 0.0007
520 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0007
521 SYSTEMIC LUPUS ERYTHEMATOSUS 23 0.0006
522 ARTHRITIS INFECTIVE 3 0.0006
523 GENERALISED OEDEMA 8 0.0006
524 BACK INJURY 7 0.0006
525 PULMONARY HAEMORRHAGE 5 0.0006
526 FEAR 17 0.0006
527 OBSTRUCTIVE AIRWAYS DISORDER 7 0.0006
528 SUBDURAL HAEMATOMA 9 0.0006
529 ATRIAL FLUTTER 5 0.0006
530 NEPHROPATHY TOXIC 7 0.0006
531 MIOSIS 5 0.0006
532 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 4 0.0006
533 ARTHROPATHY 34 0.0006
534 POLYURIA 5 0.0006
535 SEPSIS 68 0.0006
536 IMPAIRED HEALING 20 0.0006
537 RENAL IMPAIRMENT 51 0.0006
538 WALKING AID USER 4 0.0006
539 ABDOMINAL TENDERNESS 3 0.0006
540 HEMIPLEGIA 5 0.0006
541 HAEMODIALYSIS 5 0.0006
542 CONJUNCTIVITIS 11 0.0006
543 TREATMENT FAILURE 49 0.0006
544 EYELID PTOSIS 6 0.0006
545 VISION BLURRED 81 0.0006
546 BACTERAEMIA 7 0.0006
547 MUSCLE RIGIDITY 7 0.0006
548 PSEUDOMONAS INFECTION 5 0.0006
549 SKIN ULCER 15 0.0006
550 RESPIRATORY DISTRESS 16 0.0006
551 HYPERBILIRUBINAEMIA 6 0.0006
552 CHRONIC KIDNEY DISEASE 44 0.0006
553 VENTRICULAR EXTRASYSTOLES 6 0.0006
554 EYE DISCHARGE 6 0.0006
555 C-REACTIVE PROTEIN INCREASED 21 0.0006
556 LARGE INTESTINE PERFORATION 4 0.0006
557 NEURALGIA 14 0.0006
558 RHABDOMYOLYSIS 24 0.0006
559 ACCIDENTAL OVERDOSE 21 0.0006
560 URINE OUTPUT DECREASED 5 0.0006
561 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
562 GROIN PAIN 5 0.0006
563 DIALYSIS 8 0.0006
564 SUICIDE ATTEMPT 34 0.0006
565 CARDIOTOXICITY 5 0.0006
566 ISCHAEMIC STROKE 10 0.0006
567 PARALYSIS 8 0.0006
568 HEPATIC ENZYME INCREASED 38 0.0006
569 IMPAIRED QUALITY OF LIFE 8 0.0006
570 DISABILITY 11 0.0006
571 ORAL DISORDER 4 0.0005
572 PNEUMONIA BACTERIAL 5 0.0005
573 ANGIOEDEMA 24 0.0005
574 HEART RATE DECREASED 19 0.0005
575 DRY EYE 27 0.0005
576 HAEMATOMA 14 0.0005
577 OCULAR DISCOMFORT 6 0.0005
578 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 38 0.0005
579 ANHEDONIA 14 0.0005
580 CHROMATURIA 12 0.0005
581 HEPATIC FAILURE 16 0.0005
582 ECONOMIC PROBLEM 8 0.0005
583 POISONING DELIBERATE 5 0.0005
584 INJURY 37 0.0005
585 PRODUCT PACKAGING ISSUE 5 0.0005
586 EYE HAEMORRHAGE 7 0.0005
587 RECALLED PRODUCT ADMINISTERED 5 0.0005
588 DRUG DISPENSING ERROR 8 0.0005
589 INFLAMMATION 27 0.0005
590 INTERCEPTED PRODUCT ADMINISTRATION ERROR 4 0.0005
591 BRONCHOPULMONARY ASPERGILLOSIS 4 0.0005
592 HYPOGLYCAEMIA 25 0.0005
593 DRUG TOXICITY 7 0.0005
594 NEUROTOXICITY 9 0.0005
595 HAEMORRHAGIC STROKE 4 0.0005
596 DRUG INEFFECTIVE 674 0.0005
597 DRUG-INDUCED LIVER INJURY 16 0.0005
598 PLEURAL EFFUSION 31 0.0005
599 CYANOSIS 8 0.0005
600 CHOLECYSTITIS 6 0.0005
601 ULCER 8 0.0005
602 CEREBRAL HAEMORRHAGE 18 0.0005
603 HYPERTENSION 106 0.0005
604 TRANSAMINASES INCREASED 11 0.0005
605 ADRENAL INSUFFICIENCY 6 0.0005
606 ATRIAL FIBRILLATION 48 0.0005
607 VISUAL IMPAIRMENT 61 0.0005
608 MOTOR DYSFUNCTION 5 0.0005
609 LUNG DISORDER 24 0.0005
610 CHOLELITHIASIS 16 0.0005
611 CATARACT 29 0.0005
612 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 4 0.0005
613 OCULAR HYPERAEMIA 23 0.0005
614 OXYGEN SATURATION DECREASED 27 0.0005
615 URINARY RETENTION 16 0.0005
616 BLOOD UREA INCREASED 8 0.0005
617 HYPOCALCAEMIA 9 0.0005
618 PSYCHOTIC DISORDER 14 0.0005
619 HAEMATEMESIS 12 0.0005
620 MUSCULOSKELETAL STIFFNESS 41 0.0005
621 IMPAIRED WORK ABILITY 10 0.0005
622 INFUSION RELATED REACTION 31 0.0005
623 SKIN HYPERPIGMENTATION 4 0.0005
624 PRESCRIBED OVERDOSE 9 0.0005
625 LACRIMATION INCREASED 14 0.0005
626 BLISTER 26 0.0005
627 RESPIRATORY TRACT INFECTION 12 0.0005
628 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
629 BLOOD CREATINE PHOSPHOKINASE INCREASED 13 0.0005
630 LUNG INFECTION 7 0.0005
631 NERVE INJURY 5 0.0004
632 WRONG DRUG ADMINISTERED 4 0.0004
633 MALNUTRITION 5 0.0004
634 MYOSITIS 4 0.0004
635 PRODUCT ADMINISTRATION ERROR 9 0.0004
636 HYPERGLYCAEMIA 16 0.0004
637 GASTROOESOPHAGEAL REFLUX DISEASE 35 0.0004
638 GASTRIC HAEMORRHAGE 5 0.0004
639 UPPER RESPIRATORY TRACT INFECTION 20 0.0004
640 EYELID OEDEMA 5 0.0004
641 THROMBOCYTOPENIA 48 0.0004
642 DISCOMFORT 26 0.0004
643 CONDITION AGGRAVATED 129 0.0004
644 ALANINE AMINOTRANSFERASE INCREASED 26 0.0004
645 RED BLOOD CELL COUNT DECREASED 12 0.0004
646 EYE IRRITATION 24 0.0004
647 SWOLLEN TONGUE 13 0.0004
648 MEDICATION ERROR 23 0.0004
649 OVERDOSE 89 0.0004
650 NOCTURIA 5 0.0004
651 PRODUCT USE IN UNAPPROVED INDICATION 102 0.0004
652 HAEMOGLOBIN DECREASED 42 0.0004
653 CYTOPENIA 5 0.0004
654 ASCITES 12 0.0004
655 COELIAC DISEASE 4 0.0004
656 HYPERCALCAEMIA 5 0.0004
657 HYPOTONIA 4 0.0004
658 DYSARTHRIA 15 0.0004
659 TOXIC SKIN ERUPTION 4 0.0004
660 OSTEOPENIA 6 0.0004
661 DRUG INTOLERANCE 38 0.0004
662 NEOPLASM MALIGNANT 26 0.0004
663 BLOOD CHOLESTEROL INCREASED 18 0.0004
664 PELVIC PAIN 7 0.0004
665 BONE DENSITY DECREASED 12 0.0004
666 RESTLESSNESS 14 0.0004
667 ROAD TRAFFIC ACCIDENT 16 0.0004
668 JOINT SWELLING 46 0.0004
669 ADVERSE REACTION 5 0.0004
670 ASPARTATE AMINOTRANSFERASE INCREASED 20 0.0004
671 INFECTION 54 0.0004
672 NIGHT SWEATS 12 0.0004
673 ANXIETY 105 0.0004
674 RESPIRATORY DISORDER 11 0.0004
675 PRODUCT DISPENSING ERROR 8 0.0004
676 PRODUCT PRESCRIBING ISSUE 8 0.0004
677 ABNORMAL FAECES 3 0.0004
678 LETHARGY 21 0.0004
679 PULMONARY FIBROSIS 7 0.0004
680 APHASIA 11 0.0004
681 GLAUCOMA 7 0.0004
682 SWELLING 34 0.0004
683 RESPIRATORY ARREST 10 0.0004
684 EAR PAIN 7 0.0004
685 HYPOMAGNESAEMIA 5 0.0004
686 COORDINATION ABNORMAL 5 0.0004
687 EYE PRURITUS 12 0.0004
688 DEVICE OCCLUSION 5 0.0004
689 HYPONATRAEMIA 20 0.0004
690 OSTEOARTHRITIS 15 0.0004
691 SINUS DISORDER 7 0.0004
692 LOWER RESPIRATORY TRACT INFECTION 16 0.0004
693 SINUSITIS 36 0.0004
694 PRESCRIBED UNDERDOSE 7 0.0004
695 OEDEMA 19 0.0003
696 MUSCLE TWITCHING 8 0.0003
697 GASTROINTESTINAL HAEMORRHAGE 29 0.0003
698 DIPLOPIA 9 0.0003
699 TASTE DISORDER 7 0.0003
700 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 18 0.0003
701 PSORIATIC ARTHROPATHY 14 0.0003
702 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
703 SEDATION 9 0.0003
704 AGITATION 25 0.0003
705 COVID-19 PNEUMONIA 4 0.0003
706 BLOOD CREATININE INCREASED 22 0.0003
707 PULMONARY MASS 5 0.0003
708 LOSS OF CONSCIOUSNESS 43 0.0003
709 POLYNEUROPATHY 4 0.0003
710 ANAL INCONTINENCE 3 0.0003
711 GAIT INABILITY 11 0.0003
712 SMALL INTESTINAL OBSTRUCTION 4 0.0003
713 DEVICE RELATED INFECTION 5 0.0003
714 DRUG EXPOSURE DURING PREGNANCY 11 0.0003
715 ALTERED STATE OF CONSCIOUSNESS 7 0.0003
716 NECK PAIN 18 0.0003
717 OFF LABEL USE 282 0.0003
718 HAEMATURIA 11 0.0003
719 HEPATIC CIRRHOSIS 6 0.0003
720 ABDOMINAL PAIN LOWER 8 0.0003
721 LIVER DISORDER 14 0.0003
722 GASTRIC ULCER 6 0.0003
723 DISEASE RECURRENCE 15 0.0003
724 ERECTILE DYSFUNCTION 8 0.0003
725 HIATUS HERNIA 4 0.0003
726 DEEP VEIN THROMBOSIS 20 0.0003
727 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
728 TINNITUS 14 0.0003
729 URINARY INCONTINENCE 9 0.0003
730 ORAL CANDIDIASIS 4 0.0003
731 PULMONARY CONGESTION 4 0.0003
732 PERICARDIAL EFFUSION 7 0.0003
733 HAEMATOCRIT DECREASED 6 0.0003
734 BLOOD PRESSURE ABNORMAL 6 0.0003
735 MUSCULAR WEAKNESS 34 0.0003
736 EMOTIONAL DISTRESS 36 0.0003
737 CONVULSION 17 0.0003
738 UPPER GASTROINTESTINAL HAEMORRHAGE 5 0.0003
739 SINUS CONGESTION 4 0.0003
740 DRY MOUTH 24 0.0003
741 EPILEPSY 9 0.0003
742 SCAR 5 0.0003
743 LUNG NEOPLASM MALIGNANT 12 0.0003
744 CENTRAL NERVOUS SYSTEM LESION 4 0.0003
745 CONFUSIONAL STATE 47 0.0003
746 UNEVALUABLE EVENT 22 0.0003
747 PNEUMONIA 94 0.0003
748 PROSTATIC SPECIFIC ANTIGEN INCREASED 4 0.0003
749 ABDOMINAL DISTENSION 30 0.0003
750 HYPERHIDROSIS 37 0.0003
751 INTENTIONAL PRODUCT USE ISSUE 25 0.0003
752 LYMPHOCYTE COUNT DECREASED 5 0.0003
753 DRUG ERUPTION 5 0.0003
754 PRODUCT USE ISSUE 53 0.0003
755 RHEUMATOID ARTHRITIS 32 0.0003
756 HYPERTHYROIDISM 4 0.0003
757 BIPOLAR DISORDER 3 0.0003
758 HYPOKINESIA 4 0.0003
759 HYPERSENSITIVITY 51 0.0003
760 CARDIAC FAILURE 22 0.0003
761 HEPATITIS 7 0.0003
762 NEUTROPHIL COUNT DECREASED 11 0.0003
763 SLEEP DISORDER 19 0.0003
764 HEPATIC STEATOSIS 5 0.0003
765 SNEEZING 6 0.0003
766 BALANCE DISORDER 23 0.0003
767 BLOOD POTASSIUM DECREASED 8 0.0003
768 MOBILITY DECREASED 19 0.0003
769 ILL-DEFINED DISORDER 16 0.0003
770 LOWER LIMB FRACTURE 5 0.0003
771 RASH PRURITIC 14 0.0003
772 CELLULITIS 13 0.0003
773 DYSTONIA 5 0.0003
774 COGNITIVE DISORDER 12 0.0003
775 ARRHYTHMIA 12 0.0003
776 PERIPHERAL SWELLING 39 0.0003
777 PULMONARY EMBOLISM 24 0.0003
778 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
779 GENERAL PHYSICAL HEALTH DETERIORATION 29 0.0003
780 ABDOMINAL DISCOMFORT 42 0.0003
781 PYREXIA 86 0.0002
782 MENTAL IMPAIRMENT 6 0.0002
783 MYOCARDIAL INFARCTION 43 0.0002
784 URTICARIA 41 0.0002
785 EYE DISORDER 8 0.0002
786 RIB FRACTURE 5 0.0002
787 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
788 PERITONITIS 5 0.0002
789 HEPATIC FUNCTION ABNORMAL 9 0.0002
790 EXPIRED PRODUCT ADMINISTERED 8 0.0002
791 DYSPNOEA 136 0.0002
792 SOMNOLENCE 48 0.0002
793 KNEE ARTHROPLASTY 5 0.0002
794 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 8 0.0002
795 THROMBOSIS 19 0.0002
796 ANAEMIA 45 0.0002
797 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 4 0.0002
798 DRUG RESISTANCE 6 0.0002
799 SWELLING FACE 15 0.0002
800 DEAFNESS 6 0.0002
801 ARTHRITIS 18 0.0002
802 PRODUCT QUALITY ISSUE 31 0.0002
803 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
804 PLATELET COUNT DECREASED 24 0.0002
805 STEVENS-JOHNSON SYNDROME 5 0.0002
806 NERVOUS SYSTEM DISORDER 7 0.0002
807 CARDIAC FAILURE CONGESTIVE 18 0.0002
808 ERYTHEMA 46 0.0002
809 THROAT IRRITATION 10 0.0002
810 FREQUENT BOWEL MOVEMENTS 6 0.0002
811 OEDEMA PERIPHERAL 27 0.0002
812 DYSKINESIA 9 0.0002
813 CHEST PAIN 41 0.0002
814 LIMB INJURY 6 0.0002
815 HAEMORRHAGE 23 0.0002
816 MIGRAINE 21 0.0002
817 RESTLESS LEGS SYNDROME 4 0.0002
818 DEVICE DELIVERY SYSTEM ISSUE 6 0.0002
819 INSOMNIA 58 0.0002
820 INTENTIONAL PRODUCT MISUSE 19 0.0002
821 HYPOKALAEMIA 10 0.0002
822 BLOOD GLUCOSE ABNORMAL 4 0.0002
823 PROCEDURAL PAIN 6 0.0002
824 AMNESIA 14 0.0002
825 VOMITING 101 0.0002
826 DEMENTIA 6 0.0002
827 STAPHYLOCOCCAL INFECTION 7 0.0002
828 COLITIS 8 0.0002
829 CHOLESTASIS 4 0.0002
830 ABDOMINAL PAIN 48 0.0002
831 LIVER FUNCTION TEST ABNORMAL 6 0.0002
832 CHOKING 4 0.0002
833 NASAL CONGESTION 12 0.0002
834 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
835 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
836 HYPOAESTHESIA 30 0.0002
837 SYNCOPE 20 0.0002
838 PREGNANCY 4 0.0002
839 CORONARY ARTERY DISEASE 6 0.0002
840 THERAPEUTIC RESPONSE DECREASED 12 0.0002
841 STOMATITIS 12 0.0002
842 INCORRECT ROUTE OF DRUG ADMINISTRATION 7 0.0002
843 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
844 HEART RATE INCREASED 19 0.0002
845 PAIN 117 0.0002
846 DYSURIA 7 0.0002
847 HALLUCINATION, VISUAL 4 0.0002
848 RASH ERYTHEMATOUS 9 0.0002
849 EAR INFECTION 5 0.0002
850 HYPOTHYROIDISM 6 0.0002
851 BLOOD POTASSIUM INCREASED 3 0.0002
852 WHITE BLOOD CELL COUNT DECREASED 20 0.0002
853 BACK DISORDER 3 0.0002
854 NEUTROPENIA 25 0.0002
855 BLOOD PRESSURE INCREASED 28 0.0002
856 DYSPEPSIA 18 0.0002
857 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
858 COUGH 51 0.0002
859 COMPLETED SUICIDE 15 0.0002
860 CHILLS 21 0.0002
861 DYSPHAGIA 17 0.0002
862 PANCYTOPENIA 10 0.0002
863 FLUSHING 18 0.0002
864 FLUID RETENTION 9 0.0002
865 CONTUSION 17 0.0002
866 PAIN IN EXTREMITY 52 0.0002
867 DIZZINESS 88 0.0002
868 ANGINA PECTORIS 5 0.0002
869 MUSCLE SPASMS 32 0.0002
870 NAUSEA 138 0.0002
871 SKIN DISCOLOURATION 8 0.0002
872 OROPHARYNGEAL PAIN 16 0.0002
873 HOT FLUSH 13 0.0002
874 DYSSTASIA 5 0.0002
875 CEREBROVASCULAR ACCIDENT 29 0.0002
876 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
877 URINARY TRACT INFECTION 29 0.0002
878 POLLAKIURIA 7 0.0002
879 PRODUCTIVE COUGH 8 0.0002
880 MEMORY IMPAIRMENT 23 0.0002
881 PRURITUS 64 0.0002
882 DIABETIC KETOACIDOSIS 4 0.0002
883 HEADACHE 104 0.0002
884 PARAESTHESIA 26 0.0002
885 INTERSTITIAL LUNG DISEASE 8 0.0002
886 CRYING 6 0.0002
887 DRUG ADMINISTRATION ERROR 5 0.0002
888 DEPRESSION 37 0.0002
889 BRONCHITIS 12 0.0002
890 GAIT DISTURBANCE 31 0.0002
891 EYE SWELLING 6 0.0002
892 LEUKOPENIA 8 0.0002
893 ASTHMA 18 0.0002
894 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
895 DEHYDRATION 21 0.0002
896 HYPOPHAGIA 4 0.0002
897 DRUG ABUSE 13 0.0002
898 BACK PAIN 36 0.0002
899 ARTHRALGIA 64 0.0002
900 RASH 67 0.0002
901 NERVOUSNESS 8 0.0002
902 SPEECH DISORDER 8 0.0002
903 NEPHROLITHIASIS 7 0.0002
904 GASTRITIS 4 0.0002
905 NASOPHARYNGITIS 28 0.0002
906 DISORIENTATION 6 0.0002
907 PANCREATITIS 8 0.0002
908 FEBRILE NEUTROPENIA 10 0.0002
909 TREMOR 25 0.0002
910 ASTHENIA 56 0.0001
911 EXTRA DOSE ADMINISTERED 6 0.0001
912 TREATMENT NONCOMPLIANCE 8 0.0001
913 HALLUCINATION 11 0.0001
914 OSTEOPOROSIS 6 0.0001
915 PALPITATIONS 17 0.0001
916 GASTROINTESTINAL DISORDER 13 0.0001
917 FEELING COLD 4 0.0001
918 DISEASE PROGRESSION 17 0.0001
919 HAEMOPTYSIS 4 0.0001
920 WITHDRAWAL SYNDROME 6 0.0001
921 COVID-19 25 0.0001
922 PAIN IN JAW 4 0.0001
923 MENTAL DISORDER 6 0.0001
924 DECREASED APPETITE 32 0.0001
925 LABORATORY TEST ABNORMAL 4 0.0001
926 DIARRHOEA 87 0.0001
927 ADVERSE DRUG REACTION 12 0.0001
928 IRRITABILITY 8 0.0001
929 DIABETES MELLITUS 10 0.0001
930 ABDOMINAL PAIN UPPER 27 0.0001
931 FEELING HOT 8 0.0001
932 DISTURBANCE IN ATTENTION 7 0.0001
933 EMOTIONAL DISORDER 4 0.0001
934 MALAISE 56 0.0001
935 ALOPECIA 25 0.0001
936 NO ADVERSE EVENT 23 0.0001
937 CYSTITIS 4 0.0001
938 MOVEMENT DISORDER 4 0.0001
939 HIP FRACTURE 4 0.0001
940 RHINORRHOEA 8 0.0001
941 MYALGIA 21 0.0001
942 DYSGEUSIA 9 0.0001
943 LIP SWELLING 4 0.0001
944 WEIGHT DECREASED 33 0.0001
945 BLOOD GLUCOSE INCREASED 22 0.0001
946 GASTRIC DISORDER 4 0.0001
947 HYPOACUSIS 5 0.0001
948 CONSTIPATION 25 0.0001
949 DRUG WITHDRAWAL SYNDROME 10 0.0001
950 FEELING ABNORMAL 27 0.0001
951 WRONG TECHNIQUE IN DRUG USAGE PROCESS 4 0.0001
952 INCORRECT DOSE ADMINISTERED 25 0.0001
953 ADVERSE EVENT 10 0.0001
954 FATIGUE 81 0.0001
955 DYSPHONIA 6 0.0001
956 ABNORMAL BEHAVIOUR 4 0.0001
957 ACCIDENTAL EXPOSURE TO PRODUCT 10 0.0001
958 DEPRESSED MOOD 5 0.0001
959 WEIGHT INCREASED 21 0.0001
960 RECTAL HAEMORRHAGE 4 0.0001
961 DRUG EFFECT DECREASED 5 0.0001
962 PRODUCT STORAGE ERROR 8 0.0001
963 CHEST DISCOMFORT 9 0.0001
964 INJECTION SITE REACTION 6 0.0001
965 PRODUCT SUBSTITUTION ISSUE 5 0.0001
966 SURGERY 5 0.0001
967 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
968 FALL 28 0.0001
969 THERAPY INTERRUPTED 6 0.0001
970 BLOOD GLUCOSE DECREASED 4 0.0001
971 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
972 AGGRESSION 4 0.0001
973 CARDIAC DISORDER 7 0.0001
974 HAEMATOCHEZIA 4 0.0001
975 HERPES ZOSTER 4 0.0001
976 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 14 0.0001
977 EPISTAXIS 5 0.0001
978 VERTIGO 4 0.0001
979 SUICIDAL IDEATION 6 0.0001
980 DEATH 54 0.0001
981 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
982 UNDERDOSE 4 0.0001
983 PSORIASIS 7 0.0001
984 NEUROPATHY PERIPHERAL 5 0.0001
985 HOSPITALISATION 7 0.0000
986 DRY SKIN 6 0.0000
987 DEVICE ISSUE 4 0.0000
988 PRODUCT DOSE OMISSION ISSUE 12 0.0000
989 ILLNESS 4 0.0000
990 INFLUENZA 4 0.0000
991 INJECTION SITE ERYTHEMA 4 0.0000
992 DRUG DOSE OMISSION 5 0.0000